SILO insider buying and SEC filings, explained
Silo Pharma, Inc. · CIK 1514183
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Dec 15, 2025 | Purchase (code P) | Eric Weisblum (CEO and Director) bought 5,000 shares at about $0.4150 ($2K), reported as a purchase (code P). Holdings up 2% to 216,932 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 16, 2025 |
| Nov 20–21, 2025 | Purchase (code P) | Eric Weisblum (CEO and Director) bought 2,000 shares between Nov 20, 2025 and Nov 21, 2025 at $0.3700 ($740), reported as a purchase (code P). Holdings up 1% to 211,932 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 21, 2025 |
| Nov 18–19, 2025 | Purchase (code P) | Eric Weisblum (CEO and Director) bought 12,000 shares between Nov 18, 2025 and Nov 19, 2025 at about $0.4038 ($5K), reported as a purchase (code P). Holdings up 6% to 209,932 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 20, 2025 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SILO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.